A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Alexander E SullivanMichael G NannaSunil V RaoSarah E CantrellC Michael GibsonFreek W A VerheugtEric D PetersonRenato D LopesJohn H AlexanderChristopher B GrangerMegan K YeeDavid F KongPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
Double therapy in patients with AF requiring OAC following PCI or Acute coronary syndrome has a significantly better safety profile than triple therapy but may be associated with a modest increased risk of stent thrombosis.
Keyphrases
- acute coronary syndrome
- percutaneous coronary intervention
- atrial fibrillation
- antiplatelet therapy
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- pulmonary embolism
- stem cells
- mesenchymal stem cells
- coronary artery bypass
- bone marrow